|

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

RECRUITINGSponsored by Rigshospitalet, Denmark
Actively Recruiting
SponsorRigshospitalet, Denmark
Started2022-03-01
Est. completion2027-03-01
Eligibility
Age7 Years – 29 Years
Healthy vol.Accepted

Summary

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.

Eligibility

Age: 7 Years – 29 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients who are newly diagnosed with a non-CNS cancer and will undergo chemotherapy at University Hospital Copenhagen, Rigshospitalet.
* At the age of 7-29 years at diagnosis
* Each patient is matched (1:1) with a control participant within 24 months of age. The controls are recruited from the patient's own social circle and can be a friend, partner, or close family (sibling or cousin).

Exclusion Criteria:

* Unable to speak and understand Danish
* Severe intellectual disability or mental health disorder that hinders participation
* Brain metastases,
* Terminal illness
* Have had a previous chemotherapy or radiotherapy treatment

Conditions10

CancerChemo-brainChemotherapeutic ToxicityChemotherapy-Related Cognitive ImpairmentChildhood CancerHodgkin LymphomaLeukemiaNon-hodgkin LymphomaSarcomaTesticular Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.